Cyclophilin D deficiency rescues Aβ-impaired PKA/CREB signaling and alleviates synaptic degeneration
- PMID: 23507145
- PMCID: PMC3868643
- DOI: 10.1016/j.bbadis.2013.03.004
Cyclophilin D deficiency rescues Aβ-impaired PKA/CREB signaling and alleviates synaptic degeneration
Abstract
The coexistence of neuronal mitochondrial pathology and synaptic dysfunction is an early pathological feature of Alzheimer's disease (AD). Cyclophilin D (CypD), an integral part of mitochondrial permeability transition pore (mPTP), is involved in amyloid beta (Aβ)-instigated mitochondrial dysfunction. Blockade of CypD prevents Aβ-induced mitochondrial malfunction and the consequent cognitive impairments. Here, we showed the elimination of reactive oxygen species (ROS) by antioxidants probucol or superoxide dismutase (SOD)/catalase blocks Aβ-mediated inactivation of protein kinase A (PKA)/cAMP regulatory-element-binding (CREB) signal transduction pathway and loss of synapse, suggesting the detrimental effects of oxidative stress on neuronal PKA/CREB activity. Notably, neurons lacking CypD significantly attenuate Aβ-induced ROS. Consequently, CypD-deficient neurons are resistant to Aβ-disrupted PKA/CREB signaling by increased PKA activity, phosphorylation of PKA catalytic subunit (PKA C), and CREB. In parallel, lack of CypD protects neurons from Aβ-induced loss of synapses and synaptic dysfunction. Furthermore, compared to the mAPP mice, CypD-deficient mAPP mice reveal less inactivation of PKA-CREB activity and increased synaptic density, attenuate abnormalities in dendritic spine maturation, and improve spontaneous synaptic activity. These findings provide new insights into a mechanism in the crosstalk between the CypD-dependent mitochondrial oxidative stress and signaling cascade, leading to synaptic injury, functioning through the PKA/CREB signal transduction pathway.
Keywords: Alzheimer's disease; Amyloid beta; Mitochondrial permeability transition; Oxidative stress; PKA/CREB signaling; Synaptic alteration.
Copyright © 2013 Elsevier B.V. All rights reserved.
Conflict of interest statement
Figures








Similar articles
-
Cyclophilin D deficiency rescues axonal mitochondrial transport in Alzheimer's neurons.PLoS One. 2013;8(1):e54914. doi: 10.1371/journal.pone.0054914. Epub 2013 Jan 31. PLoS One. 2013. PMID: 23382999 Free PMC article.
-
Cyclophilin D deficiency attenuates mitochondrial and neuronal perturbation and ameliorates learning and memory in Alzheimer's disease.Nat Med. 2008 Oct;14(10):1097-105. doi: 10.1038/nm.1868. Epub 2008 Sep 21. Nat Med. 2008. PMID: 18806802 Free PMC article.
-
Antioxidants modulate mitochondrial PKA and increase CREB binding to D-loop DNA of the mitochondrial genome in neurons.Proc Natl Acad Sci U S A. 2005 Sep 27;102(39):13915-20. doi: 10.1073/pnas.0502878102. Epub 2005 Sep 16. Proc Natl Acad Sci U S A. 2005. PMID: 16169904 Free PMC article.
-
Mitochondrial permeability transition pore in Alzheimer's disease: cyclophilin D and amyloid beta.Biochim Biophys Acta. 2010 Jan;1802(1):198-204. doi: 10.1016/j.bbadis.2009.07.005. Epub 2009 Jul 16. Biochim Biophys Acta. 2010. PMID: 19616093 Free PMC article. Review.
-
Mitochondrial permeability transition pore is a potential drug target for neurodegeneration.Biochim Biophys Acta. 2014 Aug;1842(8):1267-72. doi: 10.1016/j.bbadis.2013.09.003. Epub 2013 Sep 18. Biochim Biophys Acta. 2014. PMID: 24055979 Free PMC article. Review.
Cited by
-
Going the Extra (Synaptic) Mile: Excitotoxicity as the Road Toward Neurodegenerative Diseases.Front Cell Neurosci. 2020 Apr 24;14:90. doi: 10.3389/fncel.2020.00090. eCollection 2020. Front Cell Neurosci. 2020. PMID: 32390802 Free PMC article. Review.
-
Geniposide Alleviates Amyloid-Induced Synaptic Injury by Protecting Axonal Mitochondrial Trafficking.Front Cell Neurosci. 2017 Jan 25;10:309. doi: 10.3389/fncel.2016.00309. eCollection 2016. Front Cell Neurosci. 2017. PMID: 28179878 Free PMC article.
-
The emerging role of peptidyl-prolyl isomerase chaperones in tau oligomerization, amyloid processing, and Alzheimer's disease.J Neurochem. 2015 Apr;133(1):1-13. doi: 10.1111/jnc.13033. Epub 2015 Feb 24. J Neurochem. 2015. PMID: 25628064 Free PMC article. Review.
-
From a Cell's Viewpoint: Targeting Mitochondria in Alzheimer's disease.Drug Discov Today Ther Strateg. 2013 Summer;10(2):e91-e98. doi: 10.1016/j.ddstr.2014.04.002. Drug Discov Today Ther Strateg. 2013. PMID: 25558270 Free PMC article.
-
A Mitocentric View of Alzheimer's Disease.Mol Neurobiol. 2017 Oct;54(8):6046-6060. doi: 10.1007/s12035-016-0117-7. Epub 2016 Oct 1. Mol Neurobiol. 2017. PMID: 27696116 Review.
References
-
- von Gunten A, Kovari E, Bussiere T, Rivara CB, Gold G, Bouras C, Hof PR, Giannakopoulos P. Cognitive impact of neuronal pathology in the entorhinal cortex and CA1 field in Alzheimer's disease. Neurobiol Aging. 2006;27:270–277. - PubMed
-
- Cummings BJ, Pike CJ, Shankle R, Cotman CW. Beta-amyloid deposition and other measures of neuropathology predict cognitive status in Alzheimer's disease. Neurobiol Aging. 1996;17:921–933. - PubMed
-
- Scheff SW, Price DA, Schmitt FA, Mufson EJ. Hippocampal synaptic loss in early Alzheimer's disease and mild cognitive impairment. Neurobiol Aging. 2006;27:1372–1384. - PubMed
-
- Selkoe DJ. Alzheimer's disease is a synaptic failure. Science. 2002;298:789–791. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases